In a further demonstration of the lure of the so-called golden triangle, pharmaceutical firm AstraZeneca has announced plans to relocate its UK-based research and development activities from Cheshire to Cambridge.
UK businesses are being failed by the government’s lack of a “coherent strategy to support the commercialisation of technological innovation in the UK”, MPs have said.
